Ebola vaccine enters Phase II trials: WRAIR
by Press Release from Outbreak News Today on (#101C3)
The Walter Reed Army Institute of Research (WRAIR) announced this week the initiation of a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers. This study includes two vaccine candidates, Ad26.ZEBOV from Crucell Holland B.V., one of the Janssen Pharmaceutical Companies ["]
